Sulfasalazine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500 mg, 1000 mg
Reference Brands: Azulfidine(US)
Category:
Arthritis
Sulfasalazine inhibits inflammatory mediators, reducing joint inflammation and pain in rheumatoid arthritis. It acts by modulating immune responses and suppressing cytokine production. Benefits include effective control of RA symptoms, slow disease progression, oral convenience, and good safety when monitored, making it a valuable disease-modifying agent.
Sulfasalazine tablets is available in Tablets
and strengths such as 500 mg, 1000 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sulfasalazine tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sulfasalazine tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sulfasalazine tablets are approved in the EU and US for treating rheumatoid arthritis and inflammatory bowel disease. In the EU, brands like Salazopyrin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, with generic versions widely available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access for sulfasalazine tablets, ensuring adherence to European and American standards for safe, effective management of autoimmune and inflammatory conditions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing